1 Study Coverage
1.1 β-blockers Product Introduction
1.2 Global β-blockers Outlook 2017 VS 2022 VS 2028
1.2.1 Global β-blockers Sales in US$ Million for the Year 2017-2028
1.2.2 Global β-blockers Sales in Volume for the Year 2017-2028
1.3 United States β-blockers Outlook 2017 VS 2022 VS 2028
1.3.1 United States β-blockers Sales in US$ Million for the Year 2017-2028
1.3.2 United States β-blockers Sales in Volume for the Year 2017-2028
1.4 β-blockers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States β-blockers in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of β-blockers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 β-blockers Market Dynamics
1.5.1 β-blockers Industry Trends
1.5.2 β-blockers Market Drivers
1.5.3 β-blockers Market Challenges
1.5.4 β-blockers Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 β-blockers Market Segment by Type
2.1.1 Nonselective Agents
2.1.2 Selective Agents
2.2 Global β-blockers Market Size by Type
2.2.1 Global β-blockers Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global β-blockers Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global β-blockers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States β-blockers Market Size by Type
2.3.1 United States β-blockers Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States β-blockers Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States β-blockers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 β-blockers Market Segment by Application
3.1.1 Abnormal Heart Rhythms
3.1.2 Hypertension
3.2 Global β-blockers Market Size by Application
3.2.1 Global β-blockers Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global β-blockers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global β-blockers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States β-blockers Market Size by Application
3.3.1 United States β-blockers Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States β-blockers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States β-blockers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global β-blockers Competitor Landscape by Company
4.1 Global β-blockers Market Size by Company
4.1.1 Top Global β-blockers Manufacturers Ranked by Revenue (2021)
4.1.2 Global β-blockers Revenue by Manufacturer (2017-2022)
4.1.3 Global β-blockers Sales by Manufacturer (2017-2022)
4.1.4 Global β-blockers Price by Manufacturer (2017-2022)
4.2 Global β-blockers Concentration Ratio (CR)
4.2.1 β-blockers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of β-blockers in 2021
4.2.3 Global β-blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global β-blockers Manufacturing Base Distribution, Product Type
4.3.1 Global β-blockers Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers β-blockers Product Type
4.3.3 Date of International Manufacturers Enter into β-blockers Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States β-blockers Market Size by Company
4.5.1 Top β-blockers Players in United States, Ranked by Revenue (2021)
4.5.2 United States β-blockers Revenue by Players (2020, 2021 & 2022)
4.5.3 United States β-blockers Sales by Players (2020, 2021 & 2022)
5 Global β-blockers Market Size by Region
5.1 Global β-blockers Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global β-blockers Market Size in Volume by Region (2017-2028)
5.2.1 Global β-blockers Sales in Volume by Region: 2017-2022
5.2.2 Global β-blockers Sales in Volume Forecast by Region (2023-2028)
5.3 Global β-blockers Market Size in Value by Region (2017-2028)
5.3.1 Global β-blockers Sales in Value by Region: 2017-2022
5.3.2 Global β-blockers Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America β-blockers Market Size YoY Growth 2017-2028
6.1.2 North America β-blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific β-blockers Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific β-blockers Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe β-blockers Market Size YoY Growth 2017-2028
6.3.2 Europe β-blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America β-blockers Market Size YoY Growth 2017-2028
6.4.2 Latin America β-blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa β-blockers Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa β-blockers Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer β-blockers Products Offered
7.1.5 Pfizer Recent Development
7.2 Novartis
7.2.1 Novartis Corporation Information
7.2.2 Novartis Description and Business Overview
7.2.3 Novartis β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis β-blockers Products Offered
7.2.5 Novartis Recent Development
7.3 Merck
7.3.1 Merck Corporation Information
7.3.2 Merck Description and Business Overview
7.3.3 Merck β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck β-blockers Products Offered
7.3.5 Merck Recent Development
7.4 Astra Zeneca
7.4.1 Astra Zeneca Corporation Information
7.4.2 Astra Zeneca Description and Business Overview
7.4.3 Astra Zeneca β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Astra Zeneca β-blockers Products Offered
7.4.5 Astra Zeneca Recent Development
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Corporation Information
7.5.2 Jhonson and Johnson Description and Business Overview
7.5.3 Jhonson and Johnson β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Jhonson and Johnson β-blockers Products Offered
7.5.5 Jhonson and Johnson Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Corporation Information
7.6.2 Eli Lilly Description and Business Overview
7.6.3 Eli Lilly β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Eli Lilly β-blockers Products Offered
7.6.5 Eli Lilly Recent Development
7.7 Sanofi
7.7.1 Sanofi Corporation Information
7.7.2 Sanofi Description and Business Overview
7.7.3 Sanofi β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sanofi β-blockers Products Offered
7.7.5 Sanofi Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporation Information
7.8.2 Bristol-Myers Squibb Description and Business Overview
7.8.3 Bristol-Myers Squibb β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bristol-Myers Squibb β-blockers Products Offered
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer β-blockers Products Offered
7.9.5 Bayer Recent Development
7.10 GSK
7.10.1 GSK Corporation Information
7.10.2 GSK Description and Business Overview
7.10.3 GSK β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.10.4 GSK β-blockers Products Offered
7.10.5 GSK Recent Development
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Corporation Information
7.11.2 Teva Pharmaceutical Description and Business Overview
7.11.3 Teva Pharmaceutical β-blockers Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Teva Pharmaceutical β-blockers Products Offered
7.11.5 Teva Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 β-blockers Industry Chain Analysis
8.2 β-blockers Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 β-blockers Distributors
8.3 β-blockers Production Mode & Process
8.4 β-blockers Sales and Marketing
8.4.1 β-blockers Sales Channels
8.4.2 β-blockers Distributors
8.5 β-blockers Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. β-blockers CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. β-blockers Market Trends
Table 3. β-blockers Market Drivers
Table 4. β-blockers Market Challenges
Table 5. β-blockers Market Restraints
Table 6. Global β-blockers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States β-blockers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global β-blockers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States β-blockers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top β-blockers Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global β-blockers Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global β-blockers Revenue Share by Manufacturer, 2017-2022
Table 13. Global β-blockers Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global β-blockers Sales Share by Manufacturer, 2017-2022
Table 15. Global β-blockers Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global β-blockers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global β-blockers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-blockers as of 2021)
Table 18. Top Players of β-blockers in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers β-blockers Product Type
Table 20. Date of International Manufacturers Enter into β-blockers Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top β-blockers Players in United States Market, Ranking by Revenue (2021)
Table 23. United States β-blockers Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States β-blockers Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States β-blockers Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States β-blockers Sales Share by Players, 2020, 2021 & 2022
Table 27. Global β-blockers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global β-blockers Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global β-blockers Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global β-blockers Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global β-blockers Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America β-blockers Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America β-blockers Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific β-blockers Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific β-blockers Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe β-blockers Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe β-blockers Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America β-blockers Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa β-blockers Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa β-blockers Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa β-blockers Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Pfizer β-blockers Product
Table 46. Pfizer Recent Development
Table 47. Novartis Corporation Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Novartis Product
Table 51. Novartis Recent Development
Table 52. Merck Corporation Information
Table 53. Merck Description and Business Overview
Table 54. Merck β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Merck Product
Table 56. Merck Recent Development
Table 57. Astra Zeneca Corporation Information
Table 58. Astra Zeneca Description and Business Overview
Table 59. Astra Zeneca β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Astra Zeneca Product
Table 61. Astra Zeneca Recent Development
Table 62. Jhonson and Johnson Corporation Information
Table 63. Jhonson and Johnson Description and Business Overview
Table 64. Jhonson and Johnson β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Jhonson and Johnson Product
Table 66. Jhonson and Johnson Recent Development
Table 67. Eli Lilly Corporation Information
Table 68. Eli Lilly Description and Business Overview
Table 69. Eli Lilly β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Eli Lilly Product
Table 71. Eli Lilly Recent Development
Table 72. Sanofi Corporation Information
Table 73. Sanofi Description and Business Overview
Table 74. Sanofi β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Sanofi Product
Table 76. Sanofi Recent Development
Table 77. Bristol-Myers Squibb Corporation Information
Table 78. Bristol-Myers Squibb Description and Business Overview
Table 79. Bristol-Myers Squibb β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Bristol-Myers Squibb Product
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. GSK Product
Table 91. GSK Recent Development
Table 92. Teva Pharmaceutical Corporation Information
Table 93. Teva Pharmaceutical Description and Business Overview
Table 94. Teva Pharmaceutical β-blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Teva Pharmaceutical Product
Table 96. Teva Pharmaceutical Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. β-blockers Customers List
Table 100. β-blockers Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. β-blockers Product Picture
Figure 2. Global β-blockers Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global β-blockers Market Size 2017-2028 (US$ Million)
Figure 4. Global β-blockers Sales 2017-2028 (K Units)
Figure 5. United States β-blockers Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States β-blockers Market Size 2017-2028 (US$ Million)
Figure 7. United States β-blockers Sales 2017-2028 (K Units)
Figure 8. United States β-blockers Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States β-blockers Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. β-blockers Report Years Considered
Figure 11. Product Picture of Nonselective Agents
Figure 12. Product Picture of Selective Agents
Figure 13. Global β-blockers Market Share by Type in 2022 & 2028
Figure 14. Global β-blockers Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global β-blockers Sales Market Share in Value by Type (2017-2028)
Figure 16. Global β-blockers Sales by Type (2017-2028) & (K Units)
Figure 17. Global β-blockers Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global β-blockers Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States β-blockers Market Share by Type in 2022 & 2028
Figure 20. United States β-blockers Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States β-blockers Sales Market Share in Value by Type (2017-2028)
Figure 22. United States β-blockers Sales by Type (2017-2028) & (K Units)
Figure 23. United States β-blockers Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States β-blockers Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Abnormal Heart Rhythms
Figure 26. Product Picture of Hypertension
Figure 27. Global β-blockers Market Share by Application in 2022 & 2028
Figure 28. Global β-blockers Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global β-blockers Sales Market Share in Value by Application (2017-2028)
Figure 30. Global β-blockers Sales by Application (2017-2028) & (K Units)
Figure 31. Global β-blockers Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global β-blockers Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States β-blockers Market Share by Application in 2022 & 2028
Figure 34. United States β-blockers Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States β-blockers Sales Market Share in Value by Application (2017-2028)
Figure 36. United States β-blockers Sales by Application (2017-2028) & (K Units)
Figure 37. United States β-blockers Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States β-blockers Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America β-blockers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America β-blockers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe β-blockers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe β-blockers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific β-blockers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific β-blockers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America β-blockers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America β-blockers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa β-blockers Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa β-blockers Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E β-blockers Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. β-blockers Value Chain
Figure 73. β-blockers Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Novartis Merck Astra Zeneca Jhonson and Johnson Eli Lilly Sanofi Bristol-Myers Squibb Bayer GSK Teva Pharmaceutical